Switch View
© PR Newswire
28.09.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLX
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf o...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.09.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MoonLake Immunotherapeutics reports on week 16 results of the VELA Phase 3 hidradenitis suppurativa program with the Nanobody® sonelokimab
News Preview
...
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Semler Scientific, Inc. of Class Action Lawsuit and Upcoming Deadlines - SMLR
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Semler Scientific, Inc. ("Semler" or the "Company") (NASDAQ: SMLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext....
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© PR Newswire
28.09.2025
ISIN: US69380Q1076
PACS Group, Inc.
PACS
LISTED
NYSE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PACS Group, Inc. - PACS
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PACS Group, Inc. ("PACS" or the "Company") (NYSE: PACS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
28.09.2025
ISIN: US8753721047
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Pomerantz Law Firm Announces the Filing of a Class Action Against Savara Inc. and Certain Officers - SVRA
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Savara Inc. ("Savara" or the "Company") (NASDAQ: SVRA) and certain officers. The class action, filed in the United States District Court for the Eastern District of Pennsylvania, and docketed under...
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: US00847X1046
Agios Pharmaceuticals Inc
AGIO
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Agios Pharmaceuticals, Inc. ("Agios" or the "Company") (NASDAQ: AGIO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. ...
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: US81728J1097
Sensus Healthcare, Inc.
SRTS
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sensus Healthcare, Inc. ("Sensus" or the "Company") (NASDAQ: SRTS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: US86627R1023
Summit Therapeutics Inc
SMMT
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Summit Therapeutics Inc. ("Summit" or the "Company") (NASDAQ: SMMT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: US2521311074
Dexcom Inc
DXCM
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DexCom, Inc. - DXCM
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: US05380C1027
AVITA Medical Inc
RCEL
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCEL
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AVITA Medical, Inc. ("Avita" or the "Company") (NASDAQ: RCEL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of aTyr Pharma, Inc. - ATYR
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of aTyr Pharma, Inc. ("aTyr" or the "Company") (NASDAQ: ATYR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
28.09.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Cytokinetics, Incorporate of Class Action Lawsuit and Upcoming Deadlines - CYTK
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Cytokinetics, Incorporate ("Cytokinetics" or the "Company") (NASDAQ: CYTK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-fre...
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: US8342033094
Soleno Therapeutics Inc
SLNO
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ: SLNO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Pomerantz Law Firm Announces the Filing of a Class Action Against Nutex Health Inc. and Certain Officers - NUTX
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX) and certain officers. The class action, filed in the United States District Court for the Southern District of Texas, and docketed under 2...
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: US05463X1063
AxoGen Inc
AXGN
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Axogen, Inc. ("Axogen" or the "Company") (NASDAQ: AXGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Themefolio
Profiler
Peergroup
© PR Newswire
28.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Lantheus Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - LNTH
News Preview
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.09.2025
ISIN: US10806X1028
BridgeBio Pharma, Inc.
BBIO
LISTED
NASDAQ
Acoramidis Begins to Reduce Cumulative Cardiovascular Outcomes Within the First Month of Treatment in Patients with ATTR-CM
News Preview
- By Month 1, numerically fewer cumulative events were observed with acoramidis compared to placebo...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.09.2025
ISIN: KYG211081248
China Medical System Holdings Ltd
867
LISTED
HKSE
China Medical System (867.HK; 8A8.SG) Positive Results from China Phase 3 Clinical Trial of Innovative Drug Ruxolitinib Cream with AD Indication
News Preview
SHENZHEN, CHINA, Sept. 28, 2025 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (“CMS”) is pleased to announce that its subsidiaries, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited...
Themefolio
Profiler
Peergroup
© PR Newswire
27.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LNTH INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Lantheus Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
News Preview
SAN DIEGO, Sept. 26, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Lantheus Holdings, Inc. (NASDAQ: LNTH) securities between February 26, 2025 and August 5, 2025, both dates inclusive (the "Class Period"), have until Monday, November 10, 2025 t...
Themefolio
Profiler
Peergroup
© PR Newswire
27.09.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
CYTOKINETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, Incorporated - CYTK
News Preview
NEW YORK and NEW ORLEANS, Sept. 26, 2025 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have untilNovember 17, 2025 to file lead plaintiff applications in a securities class action lawsuit against Cytokinet...
Themefolio
Profiler
Peergroup
© PR Newswire
27.09.2025
ISIN: US29261A1007
Encompass Health Corp
EHC
LISTED
NYSE
Rosen Law Firm Encourages Encompass Health Corporation Investors to Inquire About Securities Class Action Investigation - EHC
News Preview
NEW YORK, Sept. 26, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on beh...
Themefolio
Profiler
Peergroup
© PR Newswire
27.09.2025
ISIN: US2358511028
Danaher Corp
DHR
LISTED
NYSE
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR
News Preview
NEW YORK, Sept. 26, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Corporation (NYSE: DHR)....
Themefolio
Profiler
Peergroup
© BusinessWire
26.09.2025
ISIN: US00857U1079
agilon health inc
AGL
LISTED
NYSE
AGILON HEALTH INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of agilon health, inc. - AGL
News Preview
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has continued its investigation into agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL).
On January 5, 2024, the Company disclosed that it was slashing its 2023 profit forecasts, specifica...
Themefolio
Profiler
Peergroup
© BusinessWire
26.09.2025
ISIN: US2358511028
Danaher Corp
DHR
LISTED
NYSE
DANAHER INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Danaher Corporation - DHR
News Preview
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Danaher Corporation (NYSE: DHR).
On April 25, 2023, the Company disclosed that "[r]evenues decreased 7.0% year-over-year to $7.2 billion, with a 4.0% non-GAAP co...
Themefolio
Profiler
Peergroup
© BusinessWire
26.09.2025
ISIN: US29251M1062
Enanta Pharmaceuticals Inc
ENTA
LISTED
NASDAQ
Enanta Pharmaceuticals to Present Topline Results from its Phase 2b Study Evaluating Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV) in High-Risk Adults
News Preview
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today announced the company will hold a conference call and webcast on Monday, September 29 at 8:30 a.m. ET to share topline results from RSVHR, a Phase 2b study evaluating z...
Themefolio
Profiler
Peergroup
© BusinessWire
26.09.2025
ISIN: US7133171055
PepGen Inc
PEPG
LISTED
NASDAQ
PepGen Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
News Preview
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company developing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced the closing of its previously announced underwritten public offering of 35,937,500 shares of its common stock,...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Savara Inc. (SVRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
BENSALEM, Pa., Sept. 26, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Savara Inc. ("Savara" or the "Company") (NASDAQ: SVRA).
IF YOU ARE AN INVE...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.09.2025
ISIN: US45254E1073
Immuneering Corp
IMRX
LISTED
NASDAQ
Immuneering to Discuss Recently Announced Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Monday, September 29, 2025
News Preview
NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer patients alive, today announced that it will host a conference call and live webcast at 8:30 am ET on September 29, 2025, to discuss recently announced updated overall survival and safety data in first-l...
Themefolio
Profiler
Peergroup
© BusinessWire
26.09.2025
ISIN: CA1380357048
Canopy Growth Corp
CGC
LISTED
NASDAQ
Canopy Growth Corporation Announces Adjournment of Annual General and Special Meeting of Shareholders Due to Lack of Quorum
News Preview
Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED) (NASDAQ:CGC) today announced that, due to the requisite quorum not being present, the annual general and special meeting of shareholders (the “Meeting”) scheduled for September 26, 2025 at 1:00 p.m. Eastern Time via live webcast was convened and then adjourned. The Meeting has...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm
News Preview
NEW YORK, Sept. 26, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of LifeMD, Inc. (NASDAQ: LFMD) between May 7, 2025 and August 5, 2025, both dates inclusive (the "Cla...
Themefolio
Profiler
Peergroup
© BusinessWire
26.09.2025
ISIN: US4718712023
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
Deadline Approaching: Jasper Therapeutics, Inc. (JSPR) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
News Preview
Law Offices of Howard G. Smith reminds investors of the upcoming November 18, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR) securities between November 30, 2023 and July 3, 2025, inclusive (the “Class Period”).
IF YOU ARE A...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
26.09.2025
ISIN: US64051A1016
NeOnc Technologies Holdings Inc
NTHI
LISTED
NASDAQ
New to The Street to Broadcast Saturday, September 27th Featuring NeOnc Pharma $NTHI and Other Innovative Companies
News Preview
Bloomberg Television 6:30 PM ET as Sponsored Programming - With TV Commercials Debuting by Laser Photonics $LASE, Synergy CHC $SNYR, Sustainable Green Team $SGTM, and Acurx Pharmaceuticals $ACXP NEW YORK CITY, NEW YORK / ACCESS Newswire / September 26, 2025 / New to The Street, a leading national business television series, announces its upcoming b...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.09.2025
ISIN: FR0012882389
Equasens
EQS
LISTED
EURONEXT
Equasens: 2025 half-year results
News Preview
Villers-lès-Nancy, 26 September 2025 - 6:00 PM (CET)...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Levi & Korsinsky Notifies Shareholders of Savara Inc.(SVRA) of a Class Action Lawsuit and an Upcoming Deadline
News Preview
NEW YORK, Sept. 26, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Savara Inc. ("Savara Inc." or the "Company") (NASDAQ: SVRA) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recov...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Class Action Filed Against Nutex Health Inc. (NUTX) Seeking Recovery for Investors - Contact Levi & Korsinsky
News Preview
NEW YORK, Sept. 26, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit se...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Levi & Korsinsky Reminds Semler Scientific, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2025 - SMLR
News Preview
NEW YORK, Sept. 26, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Semler Scientific, Inc. ("Semler Scientific, Inc." or the "Company") (NASDAQ: SMLR) of a class action securities lawsuit.
CLASS DEFINITION: Th...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2025
ISIN: US0311621009
Amgen Inc
AMGN
LISTED
NASDAQ
AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS
News Preview
THOUSAND OAKS, Calif., Sept. 26, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced a $650 million expansion of its U.S. manufacturing network, creating hundreds of new jobs.
The planned investment will support increased drug production at the company's biologics manufacturing facility in Juncos and integrate innovative advanced technologi...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 25, 2025 in LifeMD, Inc. Lawsuit - LFMD
News Preview
NEW YORK, Sept. 26, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in LifeMD, Inc. ("LifeMD, Inc." or the "Company") (NASDAQ: LFMD) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to rec...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Lantheus Holdings, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before November 10, 2025 to Discuss Your Rights - LNTH
News Preview
NEW YORK, Sept. 26, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Class Action Filed Against Cytokinetics, Incorporated (CYTK) - November 17, 2025 Deadline to Join - Contact Levi & Korsinsky
News Preview
NEW YORK , Sept. 26, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Cytokinetics, Incorporated ("Cytokinetics" or the "Company") (NASDAQ: CYTK) of a class action securities lawsuit.
CLASS DEFINITION: The laws...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2025
ISIN: US02155H1014
Altimmune, Inc.
ALT
LISTED
NASDAQ
Shareholders that lost money on Altimmune, Inc.(ALT) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
News Preview
NEW YORK, Sept. 26, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Altimmune, Inc. ("Altimmune" or the "Company") (NASDAQ: ALT) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to reco...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2025
ISIN: US00287Y1091
AbbVie Inc
ABBV
LISTED
EURONEXT
AbbVie Submits New Drug Application to U.S. FDA for Tavapadon for the Treatment of Parkinson's Disease
News Preview
Submission supported by data from the Phase 3 TEMPO program that demonstrated symptomatic improvement across the Parkinson's disease spectrumPositive results across all three Phase 3 TEMPO trials reinforce the potential of tavapadon, a novel selective dopamine D1/D5 receptor partial agonist, in Parkinson's diseaseIf approved, tavapadon will enhan...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2025
ISIN: US5324571083
Eli Lilly and Co
LLY
LISTED
NYSE
Lilly opens newest Gateway Labs site in San Diego to boost local biotechnology ecosystem
News Preview
New 82,514 square foot facility will accommodate up to 15 biotech companies to fuel next-generation medicines
Gateway Labs model provides flexible lab space and tailored scientific engagement to support early-stage biotechs
INDIANAPOLIS, Sept. 26, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the official opening of its...
Themefolio
Profiler
Peergroup
© BusinessWire
26.09.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
Baxter is First Manufacturer to Achieve Gold Resiliency Badge for IV Solutions, Nutrition Solutions and Premix Drugs from Healthcare Industry Resilience Collaborative (HIRC)
News Preview
Baxter International Inc. (NYSE:BAX), a leading global medtech company, today announced that it has been awarded a Gold Level Resiliency Badge from the Healthcare Industry Resilience Collaborative (HIRC) in the categories of IV Solutions, Nutrition Solutions and Premix Drugs. Baxter is the first manufacturer to earn this distinction across these c...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2025
ISIN: US30048L3024
Evofem Biosciences, Inc
EVFM
LISTED
OTC
Evofem Biosciences Honors World Contraception Day
News Preview
SAN DIEGO, Sept. 26, 2025 /PRNewswire/ -- On World Contraception Day, Evofem Biosciences, Inc. ("Evofem" or "the Company") (OTCID: EVFM) honors the millions of people worldwide who rely on contraception not only to prevent pregnancy, but to take control of their health, their futures, and their freedom. Access to contraception remains uneven acro...
Themefolio
Profiler
Peergroup
© BusinessWire
26.09.2025
ISIN: US4364401012
Hologic Inc
HOLX
LISTED
NASDAQ
New Data on Hologic’s AI-Powered Mammography Technology to Be Presented at EUSOBI
News Preview
Data from two groundbreaking studies evaluating the performance of Hologic’s (Nasdaq: HOLX) artificial intelligence (AI)-powered mammography technology will be presented today at the European Society of Breast Imaging (EUSOBI) Annual Scientific Meeting in Aberdeen, Scotland.
This press release features multimedia. View the full release here: http...
Themefolio
Profiler
Peergroup
© BusinessWire
26.09.2025
ISIN: US00404A1097
Acadia Healthcare Company Inc
ACHC
LISTED
NASDAQ
Robbins Geller Rudman & Dowd LLP Announces Pending Class Action Lawsuit in the Acadia Healthcare Securities Litigation
News Preview
The following statement is being issued by Robbins Geller Rudman & Dowd LLP regarding the Acadia Healthcare Securities Litigation:
UNITED STATES DISTRICT COURT
MIDDLE DISTRICT OF TENNESSEE
NASHVILLE DIVISION
ST. CLAIR COUNTY EMPLOYEES’ RETIREMENT
Civil Action No. 3:18-cv-00988
SYSTEM, Individually and on Behalf of All Oth...
Themefolio
Profiler
Peergroup
© BusinessWire
26.09.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
STAAR Surgical Publishes Presentation Highlighting Compelling, Certain Cash Value Offered by Alcon Merger and Meaningful Downside Risks if Alcon Merger is not Approved
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today published a presentation reviewing the compelling, certain, premium cash value offered by the Company’s pending merger with Alcon (SIX/NYSE: ALC) and the meaningful downside risks for S...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2025
ISIN: US0043971052
Accuray Inc
ARAY
LISTED
NASDAQ
Accuray Launches All-in-One Radiotherapy Solution With Advanced Capabilities Designed to Set a New Standard in Cancer Care
News Preview
New Solution Provides an Unprecedented Set of Tools, Empowering Clinical Teams With Choice and Flexibility to Deliver Adaptive Care—Tailoring Radiotherapy to Each Patient's Unique Needs
MADISON, Wis., Sept. 26, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company is advancing its legacy of leadership in adapti...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.09.2025
ISIN: FI0009014377
Orion Oyj
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS26 September 2025 at 16.30 EEST ...
Themefolio
Profiler
Peergroup
© BusinessWire
26.09.2025
ISIN: CA24874B1085
dentalcorp Holdings Ltd.
DNTL
LISTED
TSX
Dentalcorp Agrees to be Acquired by Investment Funds Affiliated with GTCR in C$2.2 Billion Transaction
News Preview
dentalcorp Holdings Ltd. (“Dentalcorp” or the “Company”) (TSX: DNTL), Canada’s largest and one of North America’s fastest growing networks of dental practices, today announced that it has entered into a definitive arrangement agreement (the “Arrangement Agreement”) to be acquired by funds affiliated with GTCR LLC (“GTCR”), with the support of each...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.09.2025
ISIN: CA4990531069
Knight Therapeutics Inc
GUD
LISTED
TSX
Knight Therapeutics Inc. places No. 384 on The Globe and Mail's seventh annual ranking of Canada's Top Growing Companies
News Preview
MONTREAL, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:GUD) (“Knight” or “the Company”) is pleased to announce it has ranked No. 384 on the 2025 Report on Business magazine’s ranking of Canada’s Top Growing Companies....
Themefolio
Profiler
Peergroup
© BusinessWire
26.09.2025
ISIN: US4834971032
Kalvista Pharmaceuticals Inc
KALV
LISTED
NASDAQ
KalVista Pharmaceuticals to Present New EKTERLY® (sebetralstat) Data at the 20th German Allergy Congress
News Preview
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the acceptance of six abstracts for ePoster presentation at the 20th German Allergy Congress taking place in Düsseldorf, Germany from October 2–4, 2025.
Details are as follows:
Thursday, October 2 at 4:00–5:15 pm CEST:
Time to End of Progression of Hereditary Angioedema Attacks T...
Themefolio
Profiler
Peergroup
© BusinessWire
26.09.2025
ISIN: US89422G1076
Travere Therapeutics Inc
TVTX
LISTED
NASDAQ
CSL Vifor and Travere Therapeutics Recognize Updated KDIGO Clinical Practice Guidelines for IgA Nephropathy
News Preview
CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) support the recent publication of the updated clinical practice guidelines for the treatment of IgA Nephropathy (IgAN), Kidney Disease: Improving Global Outcomes (KDIGO) 2025 clinical practice guideline for the management of IgA Nephropathy and Immunoglobulin A vasculitis. The updated guidel...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2025
ISIN: US09073M1045
Bio-Techne Corp
TECH
LISTED
NASDAQ
Bio-Techne Advances Spatial Biology Solutions Bridging Translational Research to Clinical Applications
News Preview
RNAscope™ technology and the Lunaphore COMET™ enable simultaneous RNA and protein detection on the same tissue sectionTechnologies support spatial multiomic analysis and deeper insights for pathology workflowsResearch highlights potential role in clinical utility workflows for lymphoid malignancies and B-cell clonalityMINNEAPOLIS, Sept. 26, 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2025
ISIN: US45166A1025
IDEAYA Biosciences Inc
IDYA
LISTED
NASDAQ
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
News Preview
SOUTH SAN FRANCISCO, Calif., Sept. 26, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on September 25, 2025, the Compensation Committee of IDEAYA's Board of Directors granted non-qualified stock options t...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.09.2025
ISIN: US03168L1052
Amneal Pharmaceuticals Inc
AMRX
LISTED
NASDAQ
Amneal Announces BLA Submission of Biosimilar Candidate to XOLAIR® (omalizumab)
News Preview
Potential first-wave entry into the $4+ billion U.S. market and an important new growth driver for Amneal Potential first-wave entry into the $4+ billion U.S. market and an important new growth driver for Amneal...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.09.2025
ISIN: US05356F1057
Aveanna Healthcare Holdings Inc
AVAH
LISTED
NASDAQ
Aveanna to Participate at the Deutsche Bank Annual Leveraged Finance Conference
News Preview
ATLANTA, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the Deutsche Bank Annual Leveraged Finance Conference in Austin, TX on October 15, 2025. Management will host 1x1 investor meetings that day....
Themefolio
Profiler
Peergroup
© Globe Newswire
26.09.2025
ISIN: US35168W1036
Fractyl Health Inc
GUTS
LISTED
NASDAQ
Fractyl Health Announces Pricing of $60 Million Underwritten Offering of Common Stock
News Preview
Fractyl Health Announces Pricing of $60 Million Underwritten Offering of Common Stock...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
